Completed
A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer
NCT05934461
- Conditions
- The Primary Study Metric is Progression-free Survival (PFS)
- Locations
-
Not specified